Kairos Pharma Inc (KAPA): Market Value

Graphic logo of Kairos Pharma Ltd (KAPA)

The price visualization on GURU.Markets, which assists in the basic asset valuation, demonstrates the price action of Kairos Pharma Ltd (KAPA), a company integrating ESG standards and bioethics into the development of treatments for resistant tumors. The development of unique drugs will enable the firm to exercise pricing power over scarce therapies. Meanwhile, the current metric stands at 0.00, as the lack of revenue and high R&D costs lead to a predictable depletion of cash reserves.

Kairos Pharma - KAPA Market Capitalization (period 09/17/2024 - 11/15/2026)

Metric breakdowns and analytics for Kairos Pharma Limited (KAPA)

- stock exchange capitalization data:
Fundamental company valuation:Kairos Pharma KAPA
Product sample of Kairos Pharma

Kairos Pharma Ltd (KAPA) is a specialized biotechnology entity focused on oncology. By analyzing the company's market capitalization trends, an investor can determine the aggregate market value of all outstanding shares. This indicator measures the current market consensus regarding the issuer's future cash flows. For Kairos Pharma Ltd (KAPA), this metric reflects the value of its unique antibody platform and patent portfolio. The stability of this metric confirms the fundamental resilience of its innovative business model.

Competitors of Kairos Pharma Ltd (KAPA)

Market Value BeiGene Ltd ONC|Market Capitalization Halozyme Corp HALO|RVMD - Market Value|Market Valuation AAPG|CG Oncology Corp (CGON) - Market Value|Market Capitalization URGN|BCAX (Bicara Corp) - Market Capitalization|Market Valuation Personalis Corp (PSNL)|Market Capitalization ERAS|Market Capitalization delcath.com (DCTH)|Market Value YmAbs YMAB|AURA: Market Capitalization|Candel Therapeutics, Inc. - Market Capitalization|Accuray Inc. (ARAY) - Market Valuation|SELLAS Life Sciences Group Inc. (SLS) - Market Value|Market Value actuatetherapeutics.com (ACTU)|Market Value Citius Oncology|HURA: Market Value|Market Valuation TARA (Protara)|FATE (Fate Therapeutics Corp) - Market Value|Market Capitalization WHWK (Aadi Bioscience Inc)|TCRX - Market Valuation|CSBR: Market Valuation|XBIT - Market Capitalization|CVM: Market Capitalization|OS Therapies Inc - Market Value|RADX (radiopharmtheranostics.com) - Market Capitalization|Market Value Artiva Biotherapeutics, Inc. ARTV|Market Capitalization ANL|Market Value VERU (Veru)|Market Capitalization TPST (tempesttx.com)|Xilio - Market Value|RENB - Market Value|Market Value MURA (muraloncology.com)|OKUR (OnKure Therapeutics) - Market Valuation|Market Value CytoMed (GDTC)|Market Value Curis|Market Value APLM|Market Value tharimmune.com (THAR)|Market Valuation Advanced Biomed ADVB|Genprex, Inc - Market Valuation|Market Value CLDI|sunshinebiopharma.com - Market Capitalization|Market Value XBIO (xeneticbio.com)|SLRX (Salarius Pharmaceuticals) - Market Valuation|PPBT - Market Capitalization|Market Value American Oncology Network Inc|BGNE (BeiGene) - Market Value|Market Valuation CKPT (Checkpoint Therapeutics, Inc)|ELEV - Market Value|Market Capitalization ICAD (iCAD Inc.)|Ikena (IKNA) - Market Value|NTBL: Market Valuation|VIRX - Market Capitalization|MorphoSys Corp (MOR) - Market Value|Market Valuation NAYA Bio|Market Value Ascentage Pharma Group